BioNote Inc
KRX:377740
BioNote Inc
Tax Provision
BioNote Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
B
|
BioNote Inc
KRX:377740
|
Tax Provision
â‚©89B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Celltrion Inc
KRX:068270
|
Tax Provision
-â‚©108.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-17%
|
||
SK Bioscience Co Ltd
KRX:302440
|
Tax Provision
â‚©15B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
H
|
Hugel Inc
KOSDAQ:145020
|
Tax Provision
-â‚©34.9B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Tax Provision
-â‚©24.5B
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
Alteogen Inc
KOSDAQ:196170
|
Tax Provision
-â‚©8.2m
|
CAGR 3-Years
70%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
BioNote Inc
Glance View
BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
See Also
What is BioNote Inc's Tax Provision?
Tax Provision
89B
KRW
Based on the financial report for Dec 31, 2023, BioNote Inc's Tax Provision amounts to 89B KRW.